Psoriasis, a painful and uncomfortable inflammatory skin condition that affects millions worldwide, flares up from the ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Finding offers potential new target for treatmentPsoriasis, a painful and uncomfortable inflammatory skin condition that ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

20, 2025 — People with the skin condition psoriasis ... new research. These changes in the gut could explain why psoriasis sufferers often have ... Researchers Develop Nanofiber Patch for ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...

Anyone who watches television has heard the list of potential adverse reactions, considering that commercials for psoriasis treatments are ... But two new non-steroidal topicals were introduced ...

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

A study found patients treated with interleukin inhibitors did not experience a difference in the rates of major adverse ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...